Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study

NCT06897306CompletedOBSERVATIONAL

Summary

Key Facts

Lead Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Enrollment

317

Start Date

2024-10-01

Completion Date

2024-11-01

Study Type

OBSERVATIONAL

Official Title

Surgery Significantly Improves the Prognosis of Locally Advanced Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study

Interventions

surgery

Conditions

Uterine Cervical NeoplasmsSurgeryTherapyLocally Advanced Cervical Carcinoma

Eligibility

Sex

FEMALE

Inclusion Criteria:

* Patients diagnosed with Gastric - type Endocervical Adenocarcinoma were identified using the SEER database and SEER\*Stat 8.4.2 software. The search scope was the "SEER Research Plus Data, 17 Registries, Nov 2021 sub (2000 - 2019)" database. The screening criteria included "Site and Morphology, Analytic Behavior Recode = Malignant" and "Site and Morphology, ICD - O - 3 / WHO 2008 Recode Site = Cervix". Patients with Gastric - type Endocervical Adenocarcinoma in the database were selected.

Exclusion Criteria:

* Patients with a survival time of 0 or unknown.

Outcome Measures

Primary Outcomes

Overall survival (OS)

The time from diagnosis to death of the patient.

Time frame: The time from diagnosis to death of the patient,Assessed up to 227 months

Secondary Outcomes

Vital status recode(study cutoff used)

Any patient that dies after the follow-up cut-off date is recoded to alive as of the cut-off date.

Time frame: up to 227 months

Locations

The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit, Guangzhou, China

Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study